May 11-15 Performance (Crispr, Fuel Cell, Hive Blockchain, Ibio)

Here are some metrics and some notes for May 11-15.

Metrics

Security/ Project	Type	Date of Purchase	Cost of Investment	Current Value	Return %
Hive Blockchain	Stock	4/16/2020	$0.16	0.27	68.75%
Social Capital	Stock	5/1/2020	$10.20	10.52	3.14%
Fuel Cell Energy	Stock	5/3	$2.04	1.84	-9.80%
Ibio	Stock	5/11	$0.99	1.48	49.49%

Notes

- The fund sold its stake in Crispr. The link to the post explaining why we sold can be found here.

- A new stake in Ibio Pharma was started on Monday. The link explaining its purchase can be found here.  Surprisingly, it is getting to a valuation where a sale might occur.

- Some of the proceeds of the Crispr sale went to purchase more shares of Fuel Cell.


**All posts on this blog are information and opinions only. They are not to be considered recommendations to buy or sell any security. Please do your due diligence first before trading and investing. Please direct all questions and comments to the blog, kdkfund@gmail.com, or on twitter @kdkfund.

Sold Crispr Stake

The fund has sold its stake in Crispr for $60.25. Reasons for the sale are below. We still believe in the valuable work in Crispr. It is more a financial decision than anything else. We will continue to monitor its progress.

- Crispr hit a target of $60.00 far quicker than the fund believed could happen.
- Other opportunities within the biosciences sector have been found.



**All posts on this blog are information and opinions only. They are not to be considered recommendations to buy or sell any security. Please do your due diligence first before trading and investing. Please direct all questions and comments to the blog, kdkfund@gmail.com, or on twitter @kdkfund.

May 4-8 Performance (Crispr, Microvision, Hive Blockchain, Social Capital, Fuel Cell Energy)

Here are some metrics and notes for the week of May 4-8.

Security/Project	Type	Date of Purchase	Cost of Investment	Current Value	Return %
Crispr Therapeutics	Stock	3/23/2020	$38.78	53.81	38.76%
Hive Blockchain	Stock	4/16/2020	$0.16	0.33	106.25%
Social Capital	Stock	5/1/2020	$10.20	10.34	1.37%
Fuel Cell Energy	Stock	5/3	$1.93	2.1	8.81%

- Sold position in Microvision. Story link here.
- Started position in Fuel Cell Energy. Story link here.
- Bitcoin is back around $10,000 with halving coming up later this month (affecting Hive Blockchain position). 



**All posts on this blog are information and opinions only. They are not to be considered recommendations to buy or sell any security. Please do your due diligence first before trading and investing. Please direct all questions and comments to the blog, kdkfund@gmail.com, or on twitter @kdkfund.

Portfolio Weekly Performance (Crispr, Microvision, Hive Blockchain, Social Capital)

Here are some metrics and some activity notes.

Security/Project	Type	Date of Purchase	Cost of Investment	Current Value	Return %	Notes
Crispr Therapeutics	Stock	3/23/2020	$38.78	54.01	39.27%
Microvision	Stock	3/23/2020	$0.00	0.44	100.00%	Sold Cost portion. All Profit at this point
Hive Blockchain	Stock	4/16/2020	$0.16	0.23	43.75%
Social Capital	Stock	5/1/2020	$10.20	10.19	-0.10%

- Crispr released earnings this past week. Story link can be found here.
- Sold 1/2 of Microvision stock. Story here.
- Microvision releasing earnings this week. 
- Bought Social Capital. Story here. 



 **All posts on this blog are information and opinions only. They are not to be considered recommendations to buy or sell any security. Please do your due diligence first before trading and investing. Please direct all questions and comments to the blog, kdkfund@gmail.com, or on twitter @kdkfund.

Portfolio Performance (Crispr, Microvision, Hive Blockchain)

Here are some metrics and notes on the portfolio. The portfolio reflects the performance of the resources available executing the mission of KDK Fund.  

Security/Project	Type of Investment	Date of Investment Purchase	Cost of Investment	Current Value of Investment	Return %
Crispr Therapeutics	Stock	3/23/2020	$38.78	54.01	39.27%
Microvision	Stock	3/23/2020	$0.18	0.25	38.89%
Hive Blockchain	Stock	4/16/2020	$0.16	0.23	43.75%

Week's Notes

- Crispr Therapeutics - will likely be announcing earnings on April 27th.

- Hive Blockchain - Bitcoin halving in May 2020 (definition of halvening through Gemini Capital found here).

- Microvision - Company shareholder meeting on May 19th, 2020 (link here).

- The fund will continue to look for opportunities to improve the fund. The next likely entry into the portfolio will be energy related.


**All posts on this blog are information and opinions only. They are not to be considered recommendations to buy or sell any security. Please do your due diligence first before trading and investing. Please direct all questions and comments to the blog, kdkfund@gmail.com, or on twitter @kdkfund.

Hive Blockchain Added to Portfolio

Hive Blockchain shares have been added to the portfolio.We currently feel that with the current resources available, this is the right move to be in the blockchain space. Hive Blockchain has the management experience, the existence in a growing market, and access to resources needed to build wealth for its stakeholders. The plan is to hold and likely add shares to the portfolio going forward. 

From the company's website - Simply put, HIVE is a cryptocurrency mining firm. We validate transactions on blockchain networks — like Ethereum — for rewards paid in cryptocurrencies. Everyday HIVE earns new crypto coins which it can monetize for revenue and cash flow. HIVE offers shareholders exposure to the operating margins from cryptocurrency mining plus a growing portfolio of coins.


KDK Fund looks to provide capital (financial, consulting, etc.) resources to companies and projects it deems are improving life's existence. The portfolio also has an equity stake in Crispr Therapeutics (post here), and Microvision (post here).  


 **All posts on this blog are information and opinions only. They are not to be considered recommendations to buy or sell any security. Please do your due diligence first before trading and investing. Please direct all questions and comments to the blog, kdkfund@gmail.com, or on twitter @kdkfund.